Wolters Kluwer acquires Dutch tax solutions provider MFAS
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
PRESS RELEASE
Wolters Kluwer acquires Dutch tax solutions provider MFAS
Alphen aan den Rijn, October 31, 2023 – Wolters Kluwer Legal & Regulatory (LR) today announced that it has signed and completed the acquisition of MFAS, a Dutch provider of practical tax content solutions and productivity tools. MFAS will become part of Wolters Kluwer LR Benelux, which is a leading provider of information solutions and software serving legal and tax professionals in the Netherlands.
During the past 30 years, MFAS has developed a unique suite of practical tax content and tools that enhance the professional’s daily workflow, including checklists, templates, and calculation models. These solutions are used by thousands of tax specialists, accountants, and financial planners across the Netherlands to proactively support their clients in an ever-changing tax landscape. MFAS services will be integrated into Wolters Kluwer's product portfolio.
Rimco Spanjer, Vice President and Managing Director of Wolters Kluwer LR Benelux, said: “MFAS is an important player in the Dutch practical tax content market that complements our existing, distinctive software and research content for legal and tax professionals. We are pleased to be adding the practice-oriented approach of the MFAS tax solution to our offering, which fits our strategy of serving customers with expert solutions that combine deep domain knowledge with the latest technology.”
Henry Meijer, Founder and CEO at MFAS, added: “For the last thirty years, we have collaborated with our clients to develop solutions that fulfill the ever-changing needs of tax professionals. Today’s exciting news presents numerous opportunities for both MFAS and Wolters Kluwer customers. We look forward to being part of Wolters Kluwer LR Benelux and leveraging its extensive expertise in software and advanced technologies, continuing to provide impactful innovation to our expanding client base.”
Besides its two founders, MFAS has no employees. The acquisition will have an immaterial impact on Wolters Kluwer's earnings and is expected to achieve a return on invested capital (ROIC) above Wolters Kluwer’s after-tax cost of capital (8%) within 3 to 5 years.
# # #
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software, and services for professionals in Health, Tax and Accounting, Financial Corporate Compliance, Legal & Regulatory, and Corporate Performance & ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.
Media Contact
Paul Lyon
Senior Director, External Communications
Wolters Kluwer
Mobile: +44 7765 391 824
Paul.Lyon@wolterskluwer.com
Investors/Analysts
Meg Geldens
Vice President, Investor Relations
Wolters Kluwer
t +31 (0)172-641-407
ir@wolterskluwer.com
Forward-looking statements and other important legal information
This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation: general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Certain trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Omkostningsreduktion på DKK ca. 45 mio.28.11.2023 13:32:23 CET | pressemeddelelse
Selskabsmeddelelse nr. 37/2023 Holbæk, den 28. november 2023 Omkostningsreduktion på DKK ca. 45 mio. Sparekassen Sjælland Fyn A/S har i dag gennemført en reduktion af medarbejderstaben med 29 (5 % af medarbejderstaben). 21 medarbejdere er fratrådt i dag, de øvrige 8 medarbejdere er kommende pensioneringer og stillingsbortfald. Herudover er der en række øvrige driftsomkostninger, som det er lykkedes at eliminere. Samlet set bremses de årlige omkostninger med DKK ca. 45 mio. (ca. 5 %) med fuld effekt fra 1. januar 2024. ”De gennemførte medarbejder- og omkostningsreduktioner er udtryk for, at sparekassen hele tiden arbejder med at trimme forholdet mellem indtægter og omkostninger ” udtaler adm. direktør Lars Petersson. ”Virkeligheden er, at aktivitetsniveauet – særligt på boligområdet – er langt lavere end de senere år. Herudover har vi hurtigere end forventet eksekveret på en lang række teknologiske effektiviseringer jf. vores strategi. Det betyder, at vi kan drive sparekassen mere effek
Changes in the number of own shares held by Aktia Bank Plc28.11.2023 13:00:00 CET | Press release
Aktia Bank Plc Stock Exchange Release 28 November 2023 at 2.00 p.m. Changes in the number of own shares held by Aktia Bank Plc Aktia Bank Plc has today, based on a decision made by the company's Board of Directors, divested a total of 808 own shares held by the company to four persons as a deferred payment based on the company’s remuneration programs. The divestment of own shares is based on the authorisation by the Annual General Meeting of Shareholders held on 5 April 2023. After the above-mentioned divestments, a total of 159,538 shares remain in the company’s possession. Aktia Bank Plc Further information: Mia Smeds, Communications director, +358 44 546 0379, mia.smeds(at)aktia.fi Distribution: Nasdaq Helsinki Ltd Mass media www.aktia.com Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsink
Ändringar i antalet egna aktier i Aktia Bank Abp:s besittning28.11.2023 13:00:00 CET | Pressemelding
Aktia Bank Abp Börsmeddelande 28.11.2023 kl. 14.00 Ändringar i antalet egna aktier i Aktia Bank Abp:s besittning Aktia Bank Abp har idag med stöd av ett beslut av bolagets styrelse överlåtit totalt 808 Aktia-aktier i bolagets besittning till fyra personer som betalning av uppskjutna ersättningar enligt bolagets belöningssystem. Överlåtelsen av aktier är baserad på bemyndiganden av den ordinarie bolagsstämman 5.4.2023. Efter ovan nämnda överlåtelser har bolaget sammanlagt 159 538 aktier i sin besittning. Aktia Bank Abp Mera information: Mia Smeds, kommunikationsdirektör, tfn 044 546 0379, mia.smeds(at)aktia.fi Distribution: Nasdaq Helsinki Oy Massmedier www.aktia.com Aktia är en finländsk kapitalförvaltare, bank och livförsäkrare som har skapat välstånd och välfärd generation efter generation redan under 200 års tid. Vi tillhandahåller våra kunder digitala tjänster i ett flertal kanaler och ger personlig service på våra verksamhetsställen i huvudstadsregionen samt i Åbo-, Tammerfors-, V
Karolinska Developments portföljbolag Umecrine Cognition presenterar positiv effekt med golexanolon i en preklinisk modell av kolestas28.11.2023 12:44:51 CET | Pressemelding
STOCKHOLM, SVERIGE 28 november 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget Umecrine Cognition har presenterat positiva resultat från en studie med bolagets läkemedelskandidat golexanolone i en preklinisk modell av PBC-relaterad symtomologi och neuroinflammation. Resultaten indikerar en normaliserande effekt på kognitiva symtom såsom trötthet, motoriska störningar, neuroinflammation och neurala signaler. Resultaten publiceras i novemberutgåvan av den internationellt välrenommerade tidskriften Liver International. Resultaten från den prekliniska studien, som utfördes i en validerad och välkänd sjukdomsmodell av kolestas, visar att golexanolon förbättrar symtom som vanligtvis ses vid PBC. Studien visar en tydlig minskning av central trötthet, signifikanta förbättringar av korttidsminnet och normaliserande motoriska funktioner efter en 4-5 veckors lång behandling med golexanolon. ”Trötthet är högst prioriterat för symtomlindring för PBC-patienter e
Karolinska Development’s portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis28.11.2023 12:44:51 CET | Press release
STOCKHOLM, SWEDEN – November 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented positive results from a study of the company’s drug candidate golexanolone in a preclinical model of PBC-like symptomology and neuroinflammation. The results indicate a normalizing effect on cognitive symptoms, such as fatigue, motor impairments, neuroinflammation, and neural signaling. The results are published in the November issue of the internationally renowned journal Liver International. The results from the preclinical study, which was performed in a validated and well-known disease model of cholestasis, show that golexanolone improves symptoms generally seen in PBC. The study shows a clear reduction in central fatigue, marked improvements in short-term memory, and normalized motoric functions following a 4–5-week treatment regimen with golexanolone. “Fatigue is the highest priority of symptom relief for PBC patient